Advanced BRAF Mutant Melanoma
1 clinical trials · Condition
◉ Watch Advanced BRAF Mutant Melanoma
| Record | Firm | Date |
|---|---|---|
| Dabrafenib, Trametinib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma (NCT02257424) | Abramson Cancer Center at Penn Medicine | 2014-10-01 |
Track Advanced BRAF Mutant Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.